Italy |
Narration |
Assess and compare the cardiac manifestations of COVID‐19, MERS‐CoV and H1N1.(1818. Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003–8.) |
Arrhythmias; palpitations; tachycardia (Heart Rate>125bpm); ventricular/atrial fibrillation; hypotension; cardiac insufficiency; elevated troponin; hypoxemia; hypovolemia; risk for cardiac arrest; sepsis; systemic inflammatory response syndrome; acute coagulopathy; dyspnea; fatigue; pulmonary edema; acute kidney failure; fever; chills; chest pain. |
China |
Narrative |
Assess the extrarespiratory manifestations of COVID-19.(1919. Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020 ;56(2):106024.) |
Ageusia; anosmia; hyposmia; anorexia; dysgeusia; nausea/vomiting; diarrhea; abdominal pain/discomfort; arrhythmias; ccardiac insufficiency; acroischemia; dizziness; raised intracranial pressure; acute kidney failure; skin injuries; convulsion; headache; chest pain; abdominal pain/discomfort; ataxia; muscle atrophy. |
China |
Narration |
Clarify whether the SARS-CoV-2 virus can reach the central nervous system (CNS) and induce neuronal damage that leads to acute respiratory distress.(2020. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552–5.) |
Nausea/vomiting; dyspnea; fever; headache; raised intracranial pressure. |
Brazil |
Systematic |
Review the literature on neurological complications of SARS-CoV-2 infection.(2121. Munhoz RP, Pedroso JL, Nascimento FA, Almeida SM, Barsottini OG, Cardoso FE, et al. Neurological complications in patients with SARS-CoV-2 infection: a systematic review. Arq Neuropsiquiatr. 2020;78(5):290–300.) |
Ageusia; anosmia; dizziness; fatigue; convulsion; muscle pain; headache; ataxia; muscle atrophy; raised intracranial pressure. |
Iran |
Narration |
Review studies on the neurological manifestations of COVID-19.(2222. Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020;41(7):1667–71.) |
Ageusia; anosmia; hyposmia; dizziness; encephalitis; convulsion; muscle pain; headache; ataxia; muscle atrophy; raised intracranial pressure. |
France |
Narration |
Review current knowledge about neurological sequel of COVID-19 and its possible etiology.(2323. Ogier M, Andéol G, Sagui E, Dal Bo G. How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up. Brain Behav Immun Health. 2020;5:100081.) |
Dizziness; agitation; confusion; dyspnea; fever; headache; raised intracranial pressure. |
Belgium |
Narration |
Update the evidence about the prognosis of critically ill diabetic patients affected by COVID-19.(2424. Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: related risks and specifics of management. Ann Endocrinol (Paris). 2020;81(2-3):101–9.) |
Hyperglycemia; ketoacidosis; hypoxemia; oxygenation 300 mmHg; Tachypnea (Respiratory Rate > 30rpm). |
USA |
Systematic |
Describe neurological and psychological effects of COVID-19 based on a literature review.(2525. Rahman J, Muralidharan A, Quazi SJ, Saleem H, Khan S. Neurological and Psychological Effects of Coronavirus (COVID-19): An Overview of the Current Era Pandemic. Cureus. 2020;12(6):e8460.) |
Dizziness; convulsion; muscle pain; headache; raised intracranial pressure. |
Italy |
Systematic |
Synthesize the available evidence on the main neurological signs and symptoms in patients with COVID-19.(2626. Romoli M, Jelcic I, Bernard-Valnet R, García Azorín D, Mancinelli L, Akhvlediani T, et al. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur J Neurol. 2020; 27:1712-26.) |
Dizziness; agitation; cerebral hemorrhage; convulsion; headache; raised intracranial pressure. |
China |
Narration |
Report the gastrointestinal manifestations and pathological findings of patients with COVID-19 and discuss the possibility of fecal transmission of the virus.(2727. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843–51.) |
Anorexia; Nausea/vomiting; diarrhea; abdominal pain/discomfort; gastrointestinal bleeding; abdominal pain/discomfort. |
Germany |
Narration |
Present the main cutaneous symptoms described in the literature for patients with COVID-19.(2828. Wollina U, Karadağ AS, Rowland-Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID-19 patients: A review. Dermatol Ther. 2020;33(5):e13549.) |
Acroischemia; cold ends; dry gangrene; skin injuries. |
China |
Systematic |
Assess the prevalence of comorbidities in patients with COVID-19 and acute respiratory syndrome.(2929. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.) |
Dyspnea; fatigue; fever. |
China |
Narration |
Not described.(11. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11.) |
Nausea/vomiting; diarrhea; arrhythmias; elevated troponin; dyspnea; fatigue; acute kidney failure; fever; headache; sore throat. |
India |
Narration |
Summarize types, morphology, origin, transmission, symptoms and diagnostic methods of the SARS virus-CoV-2.(3030. Ramalingam K, Balasubramanian A. 2019 Novel Coronavirus: A mysterious threat from Wuhan, China–A current review. Int J Res Pharm Sci. 2020; 11(Suppl.1): 7-15.) |
Diarrhea; dyspnea; fatigue; fever; chest pain. |
Taiwan |
Narration |
Analyze the evidence on how the digestive system and liver are affected by the SARS virus-CoV-2.(3131. Lee IC, Huo TI, Huang YH. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc. 2020 ;83(6):521–3.) |
Anorexia; nausea/vomiting; diarrhea; abdominal pain/discomfort. |
China |
Narration |
Understand the mechanism of viral sepsis caused by COVID-19.(3232. Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395(10235):1517–20.) |
Weak peripheral pulse; cold ends; acute renal failure. |
Taiwan |
Narration |
Not described.(3333. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc. 2020;83(3):217–20.) |
Nausea/vomiting; diarrhea; confusion; dyspnea; hemoptysis; fever; muscle pain; headache; sore throat; chest pain. |
Poland |
Narration |
Present the typical symptoms of COVID-19.(3434. Sławiński G, Lewicka E. What should a cardiologist know about coronavirus disease 2019? Kardiol Pol. 2020;78(4):278–83.) |
Fever; muscle pain; fatigue; chest pain; systemic inflammatory response syndrome; hypoxemia; arrhythmias; elevated troponin. |
Poland |
Narration |
Present information on the etiology, pathogenesis, diagnosis, clinical picture, treatment and prevention of COVID-19.(3535. Wujtewicz M, Dylczyk-Sommer A, Aszkiełowicz A, Zdanowski S, Piwowarczyk S, Owczuk R. COVID-19 - what should anaethesiologists and intensivists know about it? Anaesthesiol Intensive Ther. 2020;52(1):34–41.) |
Fever; fatigue; muscle pain; sore throat; diarrhea; hemoptysis; chills; sepsis. |
India |
Narration |
Not described.(3636. Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol. 2020;92(7):786–90.) |
Dyspnea; muscle pain; fever; fatigue; acute kidney failure; encephalitis. |